J. Boudreau
Directeur Général chez Radcliffe Consulting & Investment Ltd.
Fortune : 29 225 $ au 30/04/2024
Profil
J.
Bernard Boudreau is currently the President & Chief Executive Officer at Radcliffe Consulting & Investment Ltd.
and a Director at Intelgenx Corp.
He previously served as Vice Chairman at IntelGenx Technologies Corp.
from 2014 to 2023, Director at Export Development Canada, Director at The Bank of Canada, Director at Pillar5 Pharma, Inc. from 2010 to 2013, and Vice President at PharmEng International, Inc. from 2005 to 2008.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
13/03/2023 | 175 000 ( 0,10% ) | 29 225 $ | 30/04/2024 |
Postes actifs de J. Boudreau
Sociétés | Poste | Début |
---|---|---|
Intelgenx Corp.
Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Directeur/Membre du Conseil | 01/06/2006 |
Radcliffe Consulting & Investment Ltd. | Directeur Général | 28/07/2011 |
Anciens postes connus de J. Boudreau
Sociétés | Poste | Fin |
---|---|---|
INTELGENX TECHNOLOGIES CORP. | Directeur/Membre du Conseil | 21/07/2023 |
Pillar5 Pharma, Inc.
Pillar5 Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pillar5 Pharma, Inc. develops, researches and manufactures sterile opthalmic and solid dose. It offers solid dose manufacturing, solid dose packaging, analytical and microbiological testing, and formulation and process development services. The company was founded in 2009 and is headquartered in Arnprior, ON. | Directeur/Membre du Conseil | 01/01/2013 |
Export Development Canada
Export Development Canada Finance/Rental/LeasingFinance Export Development Canada engages in the provision of insurance and financial services. It offers bond products, financing, insurance, and risk management solutions to help Canadian exporters and investors expand their international business. The company was founded in 1944 and is headquartered in Ottawa, Canada. | Directeur/Membre du Conseil | 01/09/2008 |
PharmEng International, Inc.
PharmEng International, Inc. Miscellaneous Commercial ServicesCommercial Services PharmEng International, Inc. was a full-service consulting and contract manufacturing company, which serves the pharmaceutical and biotechnology industries. The company was founded on October 1, 2003 and was headquartered in Markham, ON. | Corporate Officer/Principal | 01/01/2008 |
The Bank of Canada
The Bank of Canada General GovernmentGovernment The Bank of Canada provides banking and financial services. Its services include mortgage and payment processing, loan application, credit card application, accounting solutions, tax preparation, financial analysis, insurance, and payroll processing services to its clients. The company was founded in 1934 and is headquartered in Ottawa, Canada. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
INTELGENX TECHNOLOGIES CORP. | Health Technology |
Entreprise privées | 6 |
---|---|
Export Development Canada
Export Development Canada Finance/Rental/LeasingFinance Export Development Canada engages in the provision of insurance and financial services. It offers bond products, financing, insurance, and risk management solutions to help Canadian exporters and investors expand their international business. The company was founded in 1944 and is headquartered in Ottawa, Canada. | Finance |
PharmEng International, Inc.
PharmEng International, Inc. Miscellaneous Commercial ServicesCommercial Services PharmEng International, Inc. was a full-service consulting and contract manufacturing company, which serves the pharmaceutical and biotechnology industries. The company was founded on October 1, 2003 and was headquartered in Markham, ON. | Commercial Services |
Intelgenx Corp.
Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Health Technology |
The Bank of Canada
The Bank of Canada General GovernmentGovernment The Bank of Canada provides banking and financial services. Its services include mortgage and payment processing, loan application, credit card application, accounting solutions, tax preparation, financial analysis, insurance, and payroll processing services to its clients. The company was founded in 1934 and is headquartered in Ottawa, Canada. | Government |
Pillar5 Pharma, Inc.
Pillar5 Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pillar5 Pharma, Inc. develops, researches and manufactures sterile opthalmic and solid dose. It offers solid dose manufacturing, solid dose packaging, analytical and microbiological testing, and formulation and process development services. The company was founded in 2009 and is headquartered in Arnprior, ON. | Health Technology |
Radcliffe Consulting & Investment Ltd. |